Browsing Category
Pharmaceuticals
Pfizer Launches 20-valent Pneumococcal Conjugate Vaccine (PCV20) for Adults in India,…
Hyderabad: Pfizer on Monday announces the launch of its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India. With broader serotype coverage, Pfizer’s…
Zydus receives final approval from USFDA for Diltiazem Hydrochloride Tablets USP, 30…
Bengaluru : Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug…
Iberia Pharmaceuticals set to open its state-of-the-art manufacturing unit in India
New Delhi: Iberia Pharmaceuticals, a leading name in skincare, is proud to announce its new hi-tech manufacturing and research facility spread across 60000 sq. ft. in Jhajjar, Haryana. The…
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine…
Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug…
Akums Drugs & Pharmaceuticals has received ANVISA GMP Certification for its…
New Delhi: Akums Drugs & Pharmaceuticals Ltd., India’s largest contract manufacturing pharmaceutical company, is proud to announce that its Sterile Manufacturing Plant has received the…
Zydus receives tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg,…
Bengaluru: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (USFDA) for Ibrutinib tablets 140 mg, 280 mg, and 420 mg…
Akums Launches High-Strength Paracetamol Oral Suspension 500mg/5ml for Enhanced Adult…
New Delhi: Akums Drugs & Pharmaceuticals Ltd. India’s largest pharmaceutical manufacturing organisation, has announced the launch of Paracetamol Oral Suspension 500mg/5ml in the Indian…
How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme
By Vikram Aditya Sehgal
India has emerged as a global medical tourism hub, offering cost-effective and technologically advanced treatment options. It is known for its wide access to…
Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200…
Bengaluru: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug…
Alembic Pharmaceuticals acquires Utility Therapeutics for $12 million to strengthen…
Bengaluru: Alembic Pharmaceuticals, Inc., the U.S. subsidiary of Alembic Pharmaceuticals Ltd., has acquired Utility Therapeutics Ltd. (“Utility”) in a $12 million deal to strengthen its…